LPL Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-108,865
Closed -$96.5K 4658
2022
Q4
$96.5K Sell
108,865
-5,238
-5% -$6.95K ﹤0.01% 4175
2022
Q3
$179K Sell
114,103
-2,447
-2% -$5.55K ﹤0.01% 3981
2022
Q2
$234K Buy
116,550
+8,146
+8% +$14.1K ﹤0.01% 3826
2022
Q1
$253K Buy
108,404
+23,871
+28% +$74.5K ﹤0.01% 3700
2021
Q4
$393K Sell
84,533
-27,200
-24% -$169K ﹤0.01% 3483
2021
Q3
$853K Sell
111,733
-2,578
-2% -$21.9K ﹤0.01% 2748
2021
Q2
$1.11M Buy
114,311
+14,167
+14% +$113K ﹤0.01% 2478
2021
Q1
$828K Sell
100,144
-79,603
-44% -$841K ﹤0.01% 2564
2020
Q4
$1.23M Buy
179,747
+7,771
+5% +$62.4K ﹤0.01% 2030
2020
Q3
$1.92M Sell
171,976
-109,070
-39% -$998K ﹤0.01% 1483
2020
Q2
$1.76M Buy
281,046
+265,436
+1,700% +$1.02M ﹤0.01% 1423
2020
Q1
$29K Buy
+15,610
New +$45K ﹤0.01% 3124

Other funds holding SRNE